P R Hebert

1.1k total citations
14 papers, 844 citations indexed

About

P R Hebert is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Nutrition and Dietetics. According to data from OpenAlex, P R Hebert has authored 14 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Nutrition and Dietetics. Recurrent topics in P R Hebert's work include Blood Pressure and Hypertension Studies (7 papers), Sodium Intake and Health (4 papers) and Nutritional Studies and Diet (3 papers). P R Hebert is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Sodium Intake and Health (4 papers) and Nutritional Studies and Diet (3 papers). P R Hebert collaborates with scholars based in United States, Netherlands and United Kingdom. P R Hebert's co-authors include Charles H. Hennekens, Nancy R. Cook, C H Hennekens, C H Hennekens, JoAnn E. Manson, Julie E. Buring, Paul M. Ridker, B. Rosner, Janet W. Rich‐Edwards and James O. Taylor and has published in prestigious journals such as The Lancet, Circulation and Neurology.

In The Last Decade

P R Hebert

14 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P R Hebert United States 12 381 242 157 152 101 14 844
Donald A. Molony United States 20 237 0.6× 130 0.5× 142 0.9× 217 1.4× 121 1.2× 59 1.7k
Bogdan Wyrzykowski Poland 18 365 1.0× 306 1.3× 65 0.4× 105 0.7× 126 1.2× 71 992
Marie-Louise Bartelink Netherlands 12 215 0.6× 192 0.8× 189 1.2× 248 1.6× 66 0.7× 34 1.2k
Susan Connolly United Kingdom 15 437 1.1× 216 0.9× 98 0.6× 216 1.4× 75 0.7× 38 1.1k
Donatella Spotti Italy 21 144 0.4× 141 0.6× 98 0.6× 413 2.7× 96 1.0× 58 1.3k
Marquetta Faulkner United States 13 324 0.9× 69 0.3× 85 0.5× 129 0.8× 46 0.5× 22 792
Allan D. Cumming United Kingdom 18 309 0.8× 407 1.7× 54 0.3× 101 0.7× 245 2.4× 50 1.2k
Gina Lundberg United States 15 343 0.9× 179 0.7× 50 0.3× 92 0.6× 52 0.5× 49 790
Stephen R. Mascioli United States 15 348 0.9× 197 0.8× 77 0.5× 224 1.5× 71 0.7× 20 979
Richard Benfante United States 14 283 0.7× 163 0.7× 63 0.4× 320 2.1× 85 0.8× 20 1.0k

Countries citing papers authored by P R Hebert

Since Specialization
Citations

This map shows the geographic impact of P R Hebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P R Hebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P R Hebert more than expected).

Fields of papers citing papers by P R Hebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P R Hebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P R Hebert. The network helps show where P R Hebert may publish in the future.

Co-authorship network of co-authors of P R Hebert

This figure shows the co-authorship network connecting the top 25 collaborators of P R Hebert. A scholar is included among the top collaborators of P R Hebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P R Hebert. P R Hebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Asselbergs, Folkert W., Scott M. Williams, P R Hebert, et al.. (2007). Gender‐specific correlations of plasminogen activator inhibitor‐1 and tissue plasminogen activator levels with cardiovascular disease‐related traits. Journal of Thrombosis and Haemostasis. 5(2). 313–320. 40 indexed citations
2.
Kumanyika, Shiriki, Nancy R. Cook, J A Cutler, et al.. (2004). Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. Journal of Human Hypertension. 19(1). 33–45. 63 indexed citations
3.
Sokol, Seth I., Edward L. Portnay, Jeptha P. Curtis, et al.. (2004). Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke. Neurology. 63(2). 208–213. 33 indexed citations
4.
Ko, Dennis T., P R Hebert, & Christopher S. Coffey. (2004). Adverse effects of β-Blocker therapy for patients with heart failure: A quantitative overview of randomized trials. ACC Current Journal Review. 13(10). 27–27. 2 indexed citations
5.
Ko, Dennis T., P R Hebert, Christopher S. Coffey, et al.. (2002). Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. ACC Current Journal Review. 11(6). 16–16. 29 indexed citations
6.
Hebert, P R & C H Hennekens. (2000). An Overview of the 4 Randomized Trials of Aspirin Therapy in the Primary Prevention of Vascular Disease. Archives of Internal Medicine. 160(20). 3123–3123. 46 indexed citations
7.
Hennekens, Charles H., I M Lee, Nancy R. Cook, et al.. (1996). Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study.. PubMed. 275(8). 616–21. 139 indexed citations
8.
Glynn, Robert J., P R Hebert, James O. Taylor, et al.. (1995). Evidence for a positive linear relation between blood pressure and mortality in elderly people. The Lancet. 345(8953). 825–829. 145 indexed citations
9.
Ridker, P. M., et al.. (1993). Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?. The Lancet. 341(8860). 1574–1578. 34 indexed citations
10.
Hebert, P R, Janet W. Rich‐Edwards, JoAnn E. Manson, et al.. (1993). Height and incidence of cardiovascular disease in male physicians.. Circulation. 88(4). 1437–1443. 165 indexed citations
11.
Kumanyika, Shiriki, P R Hebert, J A Cutler, et al.. (1993). Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group.. Hypertension. 22(4). 502–512. 88 indexed citations
12.
Whelton, Paul K., P R Hebert, J A Cutler, et al.. (1992). Baseline characteristics of participants in phase I of the trials of hypertension prevention. Annals of Epidemiology. 2(3). 295–310. 44 indexed citations
13.
Hebert, P R, JoAnn E. Manson, & C H Hennekens. (1992). Pharmacologic therapy of mild to moderate hypertension. Journal of the American Society of Nephrology. 3(4). S135–S135. 3 indexed citations
14.
Hebert, P R. (1992). Occupation and Risk of Nonfatal Myocardial Infarction. Archives of Internal Medicine. 152(11). 2253–2253. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026